EUVIMEDEUVIMED entdecken
Crossref

Strontium‐Doped Hydroxyapatite Incorporated With Naringin for Osteoporosis Treatment

Chih-Yung Chiang, Hu Meng, Feng-Huei Lin iD, Kai-Chiang Yang iD, Chang-Chin Wu

Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-03 · 114 (3)

DOI: 10.1002/jbm.b.70059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 12.03.2026. Verfasst von Chih-Yung Chiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering and College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Flavanones, Strontium, Osteoporosis, Durapatite. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis is a highly prevalent systemic skeletal disease and a major risk factor for bone fractures. With the increase in population aging worldwide, the prevalence of osteoporosis has also increased. Nevertheless, there are unmet treatment demands for osteoporosis. Strontium plays a crucial role in bone biomineralization. Naringin is a flavanone glycoside with antiosteoporosis effects. Accordingly, this study synthesized strontium‐doped mesoporous hydroxyapatite (Hap‐Sr) particles and combined them with naringin (NHap‐Sr) for use in osteoporosis treatment. Specifically, mesoporous Hap particles were doped with Sr at various molar ratios (10%, 20%, and 30%) through coprecipitation and then combined with naringin (NHap‐Sr). These particles were characterized using X‐ray diffractometry, transmission electron microscopy, and Zetasizer analysis. Thermogravimetric analysis was conducted to determine the naringin loading efficiency. Various cell models were used to evaluate the potential cytotoxicity and effects of NHap‐Sr on bone turnover markers. The results indicated that Ca 2+ ions were replaced with Sr 2+ ions, expanding the Hap crystal lattice. Moreover, Hap‐Sr20% was the optimal sample for the formation of a mesoporous structure with a particle size of 740–1600 nm and a naringin loading efficiency of 8.5%. NHap‐Sr20% upregulated the mRNA expression levels of alkaline phosphatase, osteocalcin, osteoprotegerin, and receptor activator of nuclear factor kappa‐B ligand in osteoblast‐like cells without imposing cytotoxic effects or impairing mitochondrial membrane potential, demonstrating its ability to promote bone formation. Overall, combining Sr‐doped Hap and naringin is a promising osteoporosis treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesStrontiumOsteoporosisDurapatiteAnimalsOsteoblastsOsteoprotegerinMiceRANK LigandCell LinePorosityHumans

Stichwörter der Autor:innen

hydroxyapatitemesoporousnaringinosteoporosisstrontium

Substanzen

FlavanonesnaringinStrontiumDurapatiteOsteoprotegerinRANK LigandTnfsf11 protein, mouseTnfrsf11b protein, mouse

Autor:innen und Institutionen

  • Department of Biomedical Engineering, College of Engineering and College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Department of Orthopedics, En Chu Kong Hospital, New Taipei City, Taiwan.
  • School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
  • Centre for Advancing Electronics Dresden, Technische Universität Dresden, Dresden, Germany.
  • Medizinische Fakultät, Universität Leipzig, Leipzig, Germany.
  • Orthopedics Research Center, Taipei Medical University Hospital, Taipei, Taiwan.

ORCID-Profile: Feng-Huei Lin, Kai-Chiang Yang

Zitieren

APA

Chiang, C. Y., Meng, H., Lin, F. H., Yang, K. C., & Wu, C. C. (2026). Strontium‐Doped Hydroxyapatite Incorporated With Naringin for Osteoporosis Treatment. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(3). https://doi.org/10.1002/jbm.b.70059

Vancouver

Chiang CY, Meng H, Lin FH, Yang KC, Wu CC. Strontium‐Doped Hydroxyapatite Incorporated With Naringin for Osteoporosis Treatment. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(3). doi:10.1002/jbm.b.70059

BibTeX
@article{Chiang2026,
  author = {Chiang, Chih-Yung and Meng, Hu and Lin, Feng-Huei and Yang, Kai-Chiang and Wu, Chang-Chin},
  title = {Strontium‐Doped Hydroxyapatite Incorporated With Naringin for Osteoporosis Treatment},
  journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
  year = {2026},
  volume = {114},
  number = {3},
  doi = {10.1002/jbm.b.70059}
}
Kostenlos starten →